Variation in PSA Levels by Age, Adiposity, Race and Ethnicity, and Genetic Risk: Implications for Prostate Cancer Screening
Consideration of factors that endogenously influence PSA levels may lead to improved benefit-to-harm ratios of prostate cancer screening.
Authors
- Shakuntala Baichoo (ORCID: https://orcid.org/0000-0002-9335-1939)
- Pranoti Pradhan (ORCID: https://orcid.org/0000-0002-6423-0484)
- Kevin H. Kensler (ORCID: https://orcid.org/0000-0001-7515-7270)
- Michelle Lee-Bravatti (ORCID: https://orcid.org/0000-0002-3991-7014)
- Charlotte Roscoe (ORCID: https://orcid.org/0000-0002-9169-6458)
- Timothy Richard Rebbeck (ORCID: https://orcid.org/0000-0002-4799-1900)
- Barbra A. Dickerman (ORCID: https://orcid.org/0000-0003-2843-687X)
- Hari S. Iyer (ORCID: https://orcid.org/0000-0002-7596-9049)
- Faith Morley
- Mathias Nuris-Souquet
Institutions
- Rutgers, The State University of New Jersey (US)
- Harvard University (US)
- Oregon Health & Science University (US)
- Cornell University (US)
- Harvard University Press (US)
- Dana-Farber Cancer Institute (US)
- Weill Cornell Medicine (US)
- Rutgers Cancer Institute (US)
- École Polytechnique Fédérale de Lausanne (CH)
- University of Mauritius (MU)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-1710
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00